This product is a diamine oxidase inhibitor, which has a more obvious dilating effect on cerebrovascular and cardiovascular systems, especially on the vertebral artery system, significantly increasing the blood flow of the heart, brain and peripheral circulation, improving blood circulation, and lowering systemic blood pressure. In addition, it can increase the blood flow of the cochlea and anterior base, thereby eliminating inner ear vertigo, tinnitus and ear closure, and can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema; it can counteract the vasoconstrictive effect of catecholamines and lower arterial pressure, and has the effect of inhibiting plasma coagulation and ADP-induced platelet aggregation, can prolong the time of thrombosis in vitro in rats, and has a slight diuretic effect.

After entering the body, this product can combine with poisons containing hydroxyl or carboxyl groups to form low-toxic or non-toxic combinations that are excreted in the urine, protecting the liver and detoxifying. In addition, glucuronic acid can increase the content of liver glycogen and reduce fat reserves.

Aminoglycoside antibiotics have good antibacterial effects on various Gram-negative and Gram-positive bacteria. The mechanism of action is to bind to the 30S subunit of the bacterial ribosome and inhibit the synthesis of bacterial proteins. In recent years, the number of Gram-negative bacteria resistant to gentamicin has increased significantly.

This product is a vitamin drug. Similar to niacin, it is a component of coenzyme I and coenzyme II. It participates in the metabolic process in the body and is necessary for lipid metabolism, oxidation of tissue respiration and glycogenolysis. However, it has no vasodilatory effect. In addition, this product has the effects of preventing and treating heart block, improving sinus node function and resisting experimental tachyarrhythmias, and can significantly improve the slowing of heart rate and atrioventricular conduction block caused by verapamil.

It is a vitamin drug, similar to niacin, and is a component of coenzyme I and coenzyme II. It participates in the metabolic process in the body and is necessary for lipid metabolism, oxidation of tissue respiration and glycogenolysis. However, it has no vasodilatory effect. In addition, it has the effects of preventing and treating heart block, improving sinus node function and resisting experimental tachyarrhythmias, and can significantly improve the slowing of heart rate and atrioventricular block caused by verapamil.